Table 2.
Follow-up | ||||||
---|---|---|---|---|---|---|
Treatment/Procedure | Visit 1(baseline) | Visit 2(RFA) | Visit 3(1 mo)a | Visit 4(3 mo)a | Visit 5(6 mo)a | Visit 6(12 mo)a |
Informed consent | ● | |||||
Inclusion criteria | ● | |||||
Exclusion criteria | ● | |||||
Demographic data | ● | |||||
Physical examinationb | ● | ● | ||||
Anamnesis | ● | ● | ||||
Concomitant diseases | ● | ● | ||||
CT (Soc) | ● | ● | ● | ● | ● | |
Perfusion CT (Nsoc) | ● | |||||
Complications | ● | ● | ● | ● | ● | |
Concomitant medication | ● | ● | ||||
Occurrence of tumor | ● (Soc) | ● (Soc) | ● (Soc) | ● (Soc) |
Nsoc = Not standard of care Soc = Standard of care.
Months after RFA.
Physical examination includes height, weight, blood parameters, Karnofsky – score, ECOG - status.